Caxton Associates (New York)’s Genpact G Stock Holding History
Bought
Maintained
Sold
Other funds holding G
NIEF
Caxton Associates (New York)'s G Position: Q2 2020 in Review
Caxton Associates (New York) sold out of Genpact (G) in Q2 2020, closing a stake of 9,082 shares — an estimated $265K sold.
Caxton Associates (New York) first reported a position in G in Q3 2017 and held it in 5 quarters. The position peaked at $903K in Q4 2017. 274 funds tracked by Wall St. Rank hold G as of Q2 2020.
- Caxton Associates (New York) reported no remaining Genpact position as of Q2 2020 after selling out during the quarter.
- Caxton Associates (New York) sold 9,082 Genpact shares in Q2 2020, an estimated $265K.
- Caxton Associates (New York) first reported a position in Genpact in Q3 2017 and held it in 5 quarters.
- Caxton Associates (New York)'s Genpact position peaked at $903K in Q4 2017.
- 274 funds tracked by Wall St. Rank held Genpact as of Q2 2020.
Based on Caxton Associates (New York)'s 13F filing for Q2 2020, filed 14 Aug 2020.